Bifunctional T-cell-derived cytokines for the diagnosis of tuberculosis and treatment monitoring

Respiration

Volumn 88, Issue 3, 2014, Pages 251-261

  Essone, Paulin N ^a   Kalsdorf, Barbara ^a,b   Chegou, Novel N ^a   Loxton, André G ^a   Kriel, Magdalena ^a   Preyer, Rosemarie ^d   Ernst, Martin ^c   Walzl, Gerhard ^a   Lange, Christoph ^b,e  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b German Center for Infection Research   (Germany)

^c RESEARCH CENTER BORSTEL   (Germany)

^d AID Autoimmun Diagnostika GmbH   (Germany)

^e UNIVERSITY OF NAMIBIA   (Namibia)

Author keywords

Interferon ; Interferon release assays; Interleukin 2; Latent Mycobacterium tuberculosis infection; Tuberculosis

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; INTERLEUKIN 2; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN 65; TUBERCULIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYTOKINE; ESAT-6-CFP10 FUSION PROTEIN; HYBRID PROTEIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TREATMENT RESPONSE; CASE CONTROL STUDY; FLUOROIMMUNOASSAY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; ANTITUBERCULAR AGENTS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FLUOROIMMUNOASSAY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; LATENT TUBERCULOSIS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TREATMENT OUTCOME; TUBERCULIN; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84906578875     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000365816     Document Type: Article

References (25)

1. World Health Organization: Global tuberculosis report 2013, Geneva, World Health Organization, 2013, http://www.who.int/tb/publications/global-report/en/.
2. Lange C, Mori T: Advances in the diagnosis of tuberculosis. Respirology 2010; 15: 220-240.
3. Leung CC, Rieder HL, Lange C, Yew WW: Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur Respir J 2011; 37: 690-711.
4. Pai M, Menzies D: The new IGRA and the old TST: making good use of disagreement. Am J Respir Crit Care Med 2007; 175: 529-531.
5. Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
6. Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, Nicod LP, Cavassini M, Calandra T, Blanchet CL, Jaton K, Faouzi M, Day CL, Hanekom WA, Bart P-A, Pantaleo G: Dominant TNF-?+ Mycobacterium tuberculosisspecific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 2011; 17: 372-376.
7. Krummel B, Strassburg A, Ernst M, Reiling N, Eker B, Rath H, Hoerster R, Wappler W, Glaewe A, Schoellhorn V, Sotgiu G, Lange C: Potential role for IL-2 ELISpot in differentiating recent and remote infection in tuberculosis contact tracing. PLoS One 2010; 5:e11670.
8. Boulet S, Ndongala ML, Peretz Y, Boisvert M-P, Boulassel M-R, Tremblay C, Routy J-P, Sekaly R-P, Bernard NF: A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. J Immunol Methods 2007; 320: 18-29.
9. Millington KA, Innes JA, Hackforth S, Hinks TSC, Deeks JJ, Dosanjh DPS, Guyot-Revol V, Gunatheesan R, Klenerman P, Lalvani A: Dynamic relationship between IFN-? and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007; 178: 5217-5226.
10. Hofman FM, Kanesberg B, Smith D, Garrison D, Sevier ED: Stability of T-and B-cell numbers in human peripheral blood. Am J Clin Pathol 1982; 77: 710-713.
11. Sester U, Fousse M, Dirks J, Mack U, Prasse A, Singh M, Lalvani A, Sester M: Wholeblood flow-cytometric analysis of antigenspecific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLoS One 2011; 6:e17813.
12. Chiacchio T, Petruccioli E, Vanini V, Butera O, Cuzzi G, Petrone L, Matteucci G, Lauria FN, Franken KLMC, Girardi E, Ottenhoff THM, Goletti D: Higher frequency of T-cell response to M. Tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. PLoS One 2011; 6:e27539.
13. Ling DI, Pai M, Davids V, Brunet L, Lenders L, Meldau R, Calligaro G, Allwood B, van Zyl Smit R, Peter J, Bateman E, Dawson R, Dheda K: Are interferon-? release assays useful for diagnosing active tuberculosis in a high-burden setting? Eur Respir J 2011; 38: 649-656.
14. Markova R, Drenska R, Minchev P, Todorova Y, Ciccozzi M, Amicosante M: Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis. New Microbiol 2011; 34: 81-85.
15. Chegou NN, Essone PN, Loxton AG, Stanley K, Black GF, van der Spuy GD, van Helden PD, Franken KL, Parida SK, Klein MR, Kaufmann SHE, Ottenhoff THM, Walzl G: Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area. PLoS One 2012; 7:e38501.
16. Chegou NN, Black GF, Loxton AG, Stanley K, Essone PN, Klein MR, Parida SK, Kaufmann SHE, Doherty TM, Friggen AH, Franken KL, Ottenhoff TH, Walzl G: Potential of novel Mycobacterium tuberculosis infection phasedependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infect Dis 2012; 12: 10.
17. Aiken AM, Hill PC, Fox A, McAdam KPWJ, Jackson-Sillah D, Lugos MD, Donkor SA, Adegbola RA, Brookes RH: Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006; 6: 66.
18. Connell TG, Davies M-A, Johannisen C, Wood K, Pienaar S, Wilkinson KA, Wilkinson RJ, Zar HJ, Beatty D, Nicol MP, Curtis N, Eley B: Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children. BMC Infect Dis 2010; 10: 138-147.
19. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A: Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006; 174: 831-839.
20. Chiappini E, Della Bella C, Bonsignori F, Sollai S, Amedei A, Galli L, Niccolai E, Del Prete G, Singh M, D'Elios MM, de Martino M: Potential role of M. Tuberculosis specific IFN-? and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis. PLoS One 2012; 7:e46041.
21. Al-Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P: Restoration of mycobacterial antigen-induced proliferation and IFN-? response in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 2003; 38: 249-256.
22. Vekemans J, Lienhardt C, Sillah JS, Wheeler JG, Lahai GP, Doherty MT, Corrah T, Andersen P, McAdam KP, Marchant A: Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 2001; 69: 6554-6557.
23. Garcia M, Vargas JA, Castejon R, Navas E, Durantez A: Flow-cytometric assessment of lymphocyte cytokine production in tuberculosis. Tuberculosis (Edinb) 2002; 82: 37-41.
24. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, Wallis RS, Edmonds K, Okwera A, Mugerwa R, Peters P, Ellner JJ: Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 1999; 180: 2069-2073.
25. Chegou NN, Heyckendorf J, Walzl G, Lange C, Ruhwald M: Beyond the IFN-? horizon: biomarkers for immunodiagnosis of infection with M. Tuberculosis. Eur Respir J 2014; 43: 1472-1486.